CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise PRESIDENT AND CEO acquired 114,449 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,408 shares at $7.41 ($40,073)
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 3,200 shares at $5.97 ($19,104)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 4,500 shares at $7.10 ($31,950)
- 144 Insider Sale of Securities
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $6.16 ($33,880)
- 144 Insider Sale of Securities
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $5.64 ($31,020)
- 144 Insider Sale of Securities
Page 9 of 27 · 524 filings